Global Stem Cell Therapy Market – Analysis And Forecast (2018-2024)

Stem cells are the basic cells of the body which are used to replace or repair patients cells and are responsible for organ growth and repair and wound healing. The global stem cell therapy market is growing at significant rate due to growing awareness regarding therapeutic potency of stem cells and development of infrastructure related to stem cell banking and processing. The market has witnessed high demand for allogenic therapies over the last few years, due to easy production scale-up process, and increasing commercialization of allogeneic therapy products.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/stem-cell-therapy-market/request-sample

The growing awareness related to the therapeutic potency of stem cells, development of infrastructure related to stem cell banking and processing, development of advanced genome-based cell analysis techniques, and increasing private-public investment for the development of stem cell therapies are the primary growth drivers for stem cell therapy market. According to the World Health Organization (WHO) globally, more than 50,000 transplants are carried out annually and it is increasing each year.

Moreover, restrictions of traditional organ transplantation such as dependence on organ donor, the threat of infection, rejection, and immunosuppression threat and increasing pipeline and development of drugs for emerging applications are also boosting the growth of the stem cell therapy market.

Explore Full Report Discription at: https://www.vynzresearch.com/healthcare/stem-cell-therapy-market

The technical limitations related to production scale-up, socio-ethical issues related to the use of stem cell in disease treatment and research and unclear regulatory guidelines for product development & commercialization are the major challenges for the growth of stem cell therapy market. The socio-ethical issues involved in stem cell research such as religious briefs and destruction of human embryo are considered as the hindering factor for the adaptation of stem cell therapy by the patient.

Moreover, high cost of research, less developed research infrastructure for stem cell therapies and storage of stem cell, difficulty related with the preservation of stem cell, and strict regulations to conduct trials on human are also hindering the growth of the stem cell therapy market.

The key encounter for the new entrants is the subsistence in capital demanding and highly regulated stem cell therapy market. Moreover, the competition among the players also increases due to less product differentiation.

Geographically, North America is the largest stem cell therapy market and is observed to witness the fastest growth in the market. Some of the factors leading to the growth of the North American stem cell therapy market are increasing number of clinical trials to evaluate therapeutic potential of products, increasing prevalence of chronic diseases, the growing patient base for target diseases, growing public awareness related to the therapeutic potency of therapy, and increasing public-private funding & research grants for developing safe and effective stem cell therapy products.

Major players in the industry are capitalizing in the development of technologically inventive and advance products, which is strengthening their position in the stem cell therapy market. In March 2017, Osiris Therapeutics launched Prestige Lyotechnology, a method for storage of living cells and tissues. In addition, in February 2018, MEDIPOST announced that FDA has approved its stem cell-based Alzheimer’s disease drug, NEUROSTEM for clinical trials. Osiris Therapeutics, Inc., RTI Surgical, Inc., MEDIPOST Co., Ltd., Nuvasive, Inc., Pharmicell Co., Ltd., Holostem Terapie Avanzate Srl, JCR Pharmaceuticals Co., Ltd., Anterogen Co., Ltd., and Allosource are some of the key players offering stem cell therapy products.

Contact

VynZ Research USA

165 Broadway, 23rd Floor,

New York City, New York – 10006

United States of America

Toll-Free:1-888-253-3960

Website: https://www.vynzresearch.com

Email: support@vynzresearch.com

Connect With us: Linkedin | Twitter |Google | Facebook

VynZ Research Usa 165 Broadway, 23rd Floor, New York City, New York – 10006 United States of America Toll-Free:1-888-253-3960 Website: https://www.vynzresearch.com Email: support@vynzresearch.com